Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H19NO.ClH |
Molecular Weight | 301.811 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNCC\C=C1\C2=CC=CC=C2COC3=CC=CC=C13
InChI
InChIKey=GNPPEZGJRSOKRE-HYMQDMCPSA-N
InChI=1S/C18H19NO.ClH/c1-19-12-6-10-16-15-8-3-2-7-14(15)13-20-18-11-5-4-9-17(16)18;/h2-5,7-11,19H,6,12-13H2,1H3;1H/b16-10-;
Molecular Formula | C18H19NO |
Molecular Weight | 265.3496 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11037801
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11037801
Z-N-desmethyldoxepin is an active metabolite of doxepin, a tricyclic antidepressant. Z-N-desmethyldoxepin appeared to be a terminal oxidative metabolite, in comparison with isomeric form E-N-desmethyl-doxepin, which is undergone further oxidation under the action of CYP2D6 activity.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1981729
Curator's Comment: College of Pharmacy, University of Saskatchewan
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11037801
In 'metabolic consumption' experiments with liver microsomes (having measurable CYP2D6 activity) and initial substrate concentration of 1 microM, the consumption of E-doxepin was greater than that of Z-doxepin. With N-desmethyldoxepin, quinidine inhibited the consumption of E-N-desmethyl-doxepin whereas Z-N-desmethyldoxepin appeared to be a terminal oxidative metabolite. CYP2D6 is a major oxidative enzyme in doxepin metabolism; predominantly catalysing hydroxylation with an exclusive preference for the E-isomers. The relatively more rapid metabolism of E-isomeric forms, and the limited metabolic pathways for the Z-isomers explained the apparent enrichment of Z-N-desmethyldoxepin.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:59:28 GMT 2023
by
admin
on
Sat Dec 16 04:59:28 GMT 2023
|
Record UNII |
ZII8992NO2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6433350
Created by
admin on Sat Dec 16 04:59:28 GMT 2023 , Edited by admin on Sat Dec 16 04:59:28 GMT 2023
|
PRIMARY | |||
|
DTXSID10154462
Created by
admin on Sat Dec 16 04:59:28 GMT 2023 , Edited by admin on Sat Dec 16 04:59:28 GMT 2023
|
PRIMARY | |||
|
124694-02-6
Created by
admin on Sat Dec 16 04:59:28 GMT 2023 , Edited by admin on Sat Dec 16 04:59:28 GMT 2023
|
PRIMARY | |||
|
ZII8992NO2
Created by
admin on Sat Dec 16 04:59:28 GMT 2023 , Edited by admin on Sat Dec 16 04:59:28 GMT 2023
|
PRIMARY |